Literature DB >> 19570895

Extracellular potassium dependence of the Na+-K+-ATPase in cardiac myocytes: isoform specificity and effect of phospholemman.

Fei Han1, Amy L Tucker, Jerry B Lingrel, Sanda Despa, Donald M Bers.   

Abstract

Cardiac Na(+)-K(+)-ATPase (NKA) regulates intracellular Na(+), which in turn affects intracellular Ca(2+) and contractility via the Na(+)/Ca(2+) exchanger. Extracellular K(+) concentration ([K(+)]) is a central regulator of NKA activity. Phospholemman (PLM) has recently been recognized as a critical regulator of NKA in the heart. PLM reduces the intracellular Na(+) affinity of NKA, an effect relieved by PLM phosphorylation. Here we tested whether the NKA alpha(1)- vs. alpha(2)- isoforms have different external K(+) sensitivity and whether PLM and PKA activation affects the NKA affinity for K(+) in mouse cardiac myocytes. We measured the external [K(+)] dependence of the pump current generated by the ouabain-resistant NKA isoform in myocytes from wild-type (WT) mice (i.e., current due to NKA-alpha(1)) and mice in which the NKA isoforms have swapped ouabain affinities (alpha(1) is ouabain sensitive and alpha(2) is ouabain resistant) to assess current due to NKA-alpha(2). We found that NKA-alpha(1) has a higher affinity for external K(+) than NKA-alpha(2) [half-maximal pump activation (K(0.5)) = 1.5 +/- 0.1 vs. 2.9 +/- 0.3 mM]. The apparent external K(+) affinity of NKA was significantly lower in myocytes from WT vs. PLM-knockout mice (K(0.5) = 2.0 +/- 0.2 vs. 1.05 +/- 0.08 mM). However, PKA activation by isoproterenol (1 microM) did not alter the K(0.5) of NKA for external K(+) in WT myocytes. We conclude that 1) NKA-alpha(1) has higher affinity for K(+) than NKA-alpha(2) in cardiac myocytes, 2) PLM decreases the apparent external K(+) affinity of NKA, and 3) phosphorylation of PLM at the cytosolic domain does not alter apparent extracellular K(+) affinity of NKA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570895      PMCID: PMC2740389          DOI: 10.1152/ajpcell.00063.2009

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  38 in total

Review 1.  Mechanisms of sodium pump regulation.

Authors:  A G Therien; R Blostein
Journal:  Am J Physiol Cell Physiol       Date:  2000-09       Impact factor: 4.249

Review 2.  Electrophysiology of the sodium-potassium-ATPase in cardiac cells.

Authors:  H G Glitsch
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

3.  Homology modeling of the cation binding sites of Na+K+-ATPase.

Authors:  Haruo Ogawa; Chikashi Toyoshima
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

4.  Inhibition of the Na,K-ATPase of canine renal medulla by several local anesthetics.

Authors:  H Kutchai; L M Geddis
Journal:  Pharmacol Res       Date:  2001-04       Impact factor: 7.658

Review 5.  Structure and mechanism of Na,K-ATPase: functional sites and their interactions.

Authors:  Peter L Jorgensen; Kjell O Hakansson; Steven J D Karlish
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

6.  CHIF, a member of the FXYD protein family, is a regulator of Na,K-ATPase distinct from the gamma-subunit.

Authors:  P Béguin; G Crambert; S Guennoun; H Garty; J D Horisberger; K Geering
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

7.  Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes.

Authors:  Stéphanie Bibert; Sophie Roy; Danièle Schaer; Jean-Daniel Horisberger; Käthi Geering
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

8.  Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban.

Authors:  Jaime DeSantiago; Lars S Maier; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2002-08       Impact factor: 5.000

9.  Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties.

Authors:  Gilles Crambert; Maria Fuzesi; Haim Garty; Steven Karlish; Kathi Geering
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

Review 10.  FXYD proteins: new tissue-specific regulators of the ubiquitous Na,K-ATPase.

Authors:  Gilles Crambert; Käthi Geering
Journal:  Sci STKE       Date:  2003-01-21
View more
  31 in total

Review 1.  Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.

Authors:  Mordecai P Blaustein; Ling Chen; John M Hamlyn; Frans H H Leenen; Jerry B Lingrel; W Gil Wier; Jin Zhang
Journal:  J Physiol       Date:  2016-07-31       Impact factor: 5.182

Review 2.  How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na+ pumps are crucial.

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

3.  Knockout of the Na,K-ATPase α2-isoform in cardiac myocytes delays pressure overload-induced cardiac dysfunction.

Authors:  Tara N Rindler; Valerie M Lasko; Michelle L Nieman; Motoi Okada; John N Lorenz; Jerry B Lingrel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-22       Impact factor: 4.733

Review 4.  Electrophysiology of Hypokalemia and Hyperkalemia.

Authors:  James N Weiss; Zhilin Qu; Kalyanam Shivkumar
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-03

5.  Molecular Mechanisms and Kinetic Effects of FXYD1 and Phosphomimetic Mutants on Purified Human Na,K-ATPase.

Authors:  Neeraj Kumar Mishra; Michael Habeck; Corinna Kirchner; Haim Haviv; Yoav Peleg; Miriam Eisenstein; Hans Juergen Apell; Steven J D Karlish
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

6.  Knockout of the Na,K-ATPase α₂-isoform in the cardiovascular system does not alter basal blood pressure but prevents ACTH-induced hypertension.

Authors:  Tara N Rindler; Iva Dostanic; Valerie M Lasko; Michelle L Nieman; Jonathan C Neumann; John N Lorenz; Jerry B Lingrel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

7.  Stabilization of the α2 isoform of Na,K-ATPase by mutations in a phospholipid binding pocket.

Authors:  Einat Kapri-Pardes; Adriana Katz; Haim Haviv; Yasser Mahmmoud; Micha Ilan; Irena Khalfin-Penigel; Shmuel Carmeli; Oded Yarden; Steven J D Karlish
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

8.  Surface charges of the membrane crucially affect regulation of Na,K-ATPase by phospholemman (FXYD1).

Authors:  Erica Cirri; Corinna Kirchner; Simon Becker; Adriana Katz; Steven J Karlish; Hans-Jürgen Apell
Journal:  J Membr Biol       Date:  2013-10-09       Impact factor: 1.843

9.  Molecular Basis of Hypokalemia-Induced Ventricular Fibrillation.

Authors:  Arash Pezhouman; Neha Singh; Zhen Song; Michael Nivala; Anahita Eskandari; Hong Cao; Aneesh Bapat; Christopher Y Ko; Thao Nguyen; Zhilin Qu; Hrayr S Karagueuzian; James N Weiss
Journal:  Circulation       Date:  2015-08-12       Impact factor: 29.690

10.  Importance of the Voltage Dependence of Cardiac Na/K ATPase Isozymes.

Authors:  Christopher M Stanley; Dominique G Gagnon; Adam Bernal; Dylan J Meyer; Joshua J Rosenthal; Pablo Artigas
Journal:  Biophys J       Date:  2015-11-03       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.